Introduction

Company name: Boehringer Ingelheim Limited

Address: Ellesfield Avenue

Bracknell

Berkshire RG12 8YS

Telephone: Sales & Marketing Enquiries 01344 746959

Telephone: Technical Enquiries 01344 746957

Fax: 01344 741349

Presentation

White granules. Each gram of granules contains 16 micrograms of clenbuterol hydrochloride.

Uses

Treatment of respiratory disease in horses where airway obstruction due to bronchospasm and/or accumulation of mucus is a contributing factor, and improved mucociliary clearance is desirable. To be used alone or as adjuvant therapy.

In particular:

1.Acute, sub-acute and chronic infections where the presence of mucus and/or micro-organisms may stimulate bronchospasm or cause airway obstruction and thus increase airway resistance. For example, bronchitis, bronchiolitis and bronchopneumonia alone, or associated with equine influenza and other viral respiratory diseases.

2.Acute, sub-acute and chronic respiratory allergies.

3.Chronic Obstructive Pulmonary Disease (COPD).

In cases accompanied by bacterial infection the administration of antimicrobial agents is recommended.

Dosage and administration

Administer 5 g Ventipulmin Granules per 100 kg bodyweight twice daily.

This is equivalent to twice daily administration of 0.8 micrograms clenbuterol per kg bodyweight.

The granules should be added to the feed. A measuring scoop is provided with the 500 g pack. When full, the scoop contains 10 g. A scored line on the scoop indicates a half measure (5 g). Add to feed immediately before administration. Discard any remaining medicated feed.

Treatment should continue for as long as necessary.

Contra-indications, warnings, etc

Known hypersensitivity to the active ingredient. Clenbuterol may cause side effects such as sweating (mainly neck region), muscle tremor, tachycardia, slight hypotension or restlessness. These are typical for β-agonists and occur rarely.

Ventipulmin antagonises the effects of prostaglandin F2α and oxytocin.

Ventipulmin is antagonised by β-adrenergic blocking agents.

If used during pregnancy, treatment must be discontinued at the expected time of delivery since uterine contractions may be abolished under its influence.

Withdrawal period

Animals must not be slaughtered for human consumption during treatment. Horses may be slaughtered for human consumption only after 28 days from the last treatment.

When using do not eat, drink or smoke. After use wash any contaminated skin immediately with soap and clean water. This product contains clenbuterol, a β-agonist. Avoid inhaling dust.

Unused product and containers should be disposed of in accordance with national requirements.

For animal treatment only. Keep out of the reach and sight of children.

Pharmaceutical precautions

Protect from light. Do not store above 30°C.

Legal category

POM-V

Packaging Quantities

Screw top polythene bottle containing 500 g granules.

Further information

Nil.

Marketing authorisation number

Vm 00015/4040.